文献速递慢性肾脏病血液净化与透析

肺超声评估慢性肾脏病患者容量状态的应用

Use of Lung Ultrasound for the Assessment of Volume Status in CKD.
PubMed 文献 · Am J Kidney Dis · 2017-12-21

本文综述了肺超声(LUS)通过评估血管外肺水来评价肾脏病患者容量状态的研究,比较了LUS与其他容量评估方法,并总结了LUS与身体功能、死亡率和心血管事件等结局的关联,认为该无创床旁技术在肾内科具有重要临床潜力。

要点

  • 容量评估是肾内科管理的关键环节,容量超负荷是可干预的风险因素。
  • 肺超声通过评估血管外肺水,为容量状态提供无创床旁评估手段。
  • 肺超声与患者身体功能、死亡率和心血管事件等结局相关。

核心结论

  • 肺超声作为一种简单的床旁无创技术,在肾内科容量评估中具有显著的临床潜力。

研究设计与样本

  • 本文为综述,汇总了比较肺超声与其他容量评估方法在肾脏病患者中应用的研究,并总结肺超声与不同结局的关联。

主要发现

  • 肺超声通过评估血管外肺水受到临床研究越来越多的关注。
  • 肺超声与身体功能、死亡率和心血管事件等结局存在关联。

临床怎么用

  • 肺超声可作为肾内科患者容量状态评估的无创床旁工具,辅助临床决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Adequate assessment of fluid status is an imperative objective in the management of all types of patients in cardiology, intensive care, and especially nephrology. Fluid overload is one of the most common modifiable risk factors directly associated with hypertension, heart failure, left ventricular hypertrophy, and eventually, higher morbidity and mortality risk in these categories of patients. Different methods are commonly used to determine fluid status (eg, clinical assessment, natriuretic peptide concentrations, echocardiography, inferior vena cava measurements, or bioimpedance analysis). In recent years, lung ultrasonography (LUS), through the assessment of extravascular lung water, has received growing attention in clinical research. This article summarizes available studies that compare LUS with other methods for fluid status assessment in patients with kidney diseases. At the same time, it also presents the association of LUS with different outcomes (physical functioning, mortality, and cardiovascular events) in the same population. It appears that this simple bedside noninvasive technique has significant clinical potential in nephrology.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Covic A, Siriopol D, Voroneanu L, et al. Use of Lung Ultrasound for the Assessment of Volume Status in CKD. Am J Kidney Dis. 2017. PMID: 29274919. doi:10.1053/j.ajkd.2017.10.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。